Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Sep 9, 2022--
The "Cardiac Markers Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.
This report provides comprehensive information about the Cardiac Markers Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Cardiac Markers Rapid Tests & Point of Care (POC) are rapid diagnostic tests which are simple to perform, ready to use, accurate, economic and for infield use suggested for individuals suspected with any indication.
Scope
Reasons to Buy
The report enables you to:
Key Topics Covered:
1 Table of Contents
2 Introduction
2.1 Cardiac Markers Rapid Tests & POC Overview
3 Products under Development
3.1 Cardiac Markers Rapid Tests & POC - Pipeline Products by Stage of Development
3.2 Cardiac Markers Rapid Tests & POC - Pipeline Products by Segment
3.3 Cardiac Markers Rapid Tests & POC - Pipeline Products by Territory
3.4 Cardiac Markers Rapid Tests & POC - Pipeline Products by Regulatory Path
3.5 Cardiac Markers Rapid Tests & POC - Pipeline Products by Estimated Approval Date
4 Cardiac Markers Rapid Tests & POC - Pipeline Products under Development by Companies
4.1 Cardiac Markers Rapid Tests & POC Companies - Pipeline Products by Stage of Development
4.2 Cardiac Markers Rapid Tests & POC - Pipeline Products by Stage of Development
5 Cardiac Markers Rapid Tests & POC Companies and Product Overview
6 Cardiac Markers Rapid Tests & POC- Recent Developments
6.1 Dec 15, 2021: Trinity Biotech Announces Q3 2021 Results, the Entry Into a $81,250,000 Loan Facility to Refinance the Company's Exchangeable Senior Notes and Agreements To Repurchase Outstanding Exchangeable Senior Notes
6.2 Sep 01, 2021: BioMerieux announce First-Half 2021 Results
6.3 Jul 16, 2021: Trinity Biotech Provides a Business Development Update For Q2 2021
7 Appendix
Companies Mentioned
For more information about this report visit https://www.researchandmarkets.com/r/kzfj9s
Source: GlobalData
View source version on businesswire.com:https://www.businesswire.com/news/home/20220909005202/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH GENERAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 09/09/2022 05:34 AM/DISC: 09/09/2022 05:34 AM
http://www.businesswire.com/news/home/20220909005202/en